GLP-1ClinicsNearMe

GLP-1 Clinics in Greensboro, North Carolina

Searching for a GLP-1 provider in your area? Our directory lists 16 verified providers serving Greensboro, North Carolina (307,381 residents · 34.5% adult obesity).

Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.

Find Your Clinic ↓Browse Full Directory →

Top 10 GLP-1 Clinics in Greensboro

4.7

Allure Medical Greensboro — Physician-supervised GLP-1 programs at 1132 N Church St. Metabolic testing, nutrition guidance, psychology-supported behavior change, and body sculpting services. 4.8H

SemaglutideIn-Person

Greensboro, NC

4.4

Restoration MedSpa — GLP-1 weight loss with personalized plans for Greensboro and High Point area. Combines medical weight loss with aesthetic treatments. 4.8H

SemaglutideIn-Person

Greensboro, NC

4.1

Glow Aesthetics NC — Semaglutide GLP-1 injections with Nurse Practitioner guidance. Starts with lower dose and increases gradually to minimize side effects. 4.8H

OzempicIn-Person

More GLP-1 Resources

Independent network of GLP-1 resources serving Greensboro and patients across the U.S.

What to Look for in a GLP-1 Clinic

Choosing the right GLP-1 provider in Greensboro matters. Look for clinics that offer:

GLP-1 Medications Explained

GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:

Cost & Insurance in North Carolina

NC Medicaid covers GLP-1 for diabetes only.

For state regulation info, see the North Carolina Medical Board.

Frequently Asked Questions

How many GLP-1 clinics are in Greensboro?

Our directory lists 16 verified GLP-1 clinics in the Greensboro area, with rankings based on patient reviews, services offered, and verified provider status.

Does insurance cover GLP-1 medications in North Carolina?

NC Medicaid covers GLP-1 for diabetes only.

Are compounded GLP-1 medications still available?

Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.